On (b)(6) 2014, a double valve replacement was performed.This 27 mm epic valve was implanted in the mitral position, and a 29 mm epic valve (serial unknown) in the tricuspid position.Since (b)(6) 2016, the patient had been symptomatic with cardiac insufficiency.On an unknown date, an echocardiogram detected that one of the cusps of 27 mm epic valve (mitral) was not moving normally.On (b)(6) 2017, a re-do mitral valve replacement was performed due to mitral regurgitation and the 27 mm valve was explanted.Upon explant, there was a large perforation found on one cusp which was consistent with the abnormal movement noted by echocardiogram as it was located towards the posterior leaflet.Subsequently, a 25 mm carpentier-edwards perimount magna ease mitral heart valve was implanted.The patient has been in stable condition postoperatively.The 29 mm epic valve remains implanted in the tricuspid position with no issues.According to the surgeon, the patient has had a medical history of active infective endocarditis which may have led to this incident.
|
The results of the investigation concluded that cusps 1 and 2 contained tears and degenerative changes with loss of collagen fibers, while cusp 3 contained outflow pannus.Special stains were negative for organisms and no acute inflammation or significant calcifications were present in the valve.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.There was no evidence found to suggest the causes of the tears, collagen loss or pannus were due to an intrinsic defect in the valve, as supported by the review of the device history record and by the analysis performed.The cause for the reported event remains unknown.
|